Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer
Alice Boilève(Institut Gustave Roussy), Fanny Jaulin(Inserm), Mohamed Amine Bani(Institut Gustave Roussy), Rémy Nicolle(Centre National de la Recherche Scientifique), Maud Ngo‐Camus(Institut Gustave Roussy), Claudio Nicotra(Institut Gustave Roussy), Maximiliano Gelli(Université Paris-Saclay), Jérôme Cartry(Inserm), Marine Valéry(Institut Gustave Roussy), Peggy Dartigues(Institut Gustave Roussy), Maxime Annereau(Institut Gustave Roussy), Lambros Tselikas(Society of Interventional Radiology), Antoîne Italiano(Memorial Sloan Kettering Cancer Center), Bastien Job(Institut Gustave Roussy), Simona Cosconea(Institut Gustave Roussy), Jacques R.R. Mathieu(Délégation Paris 5), Michel Ducreux(Université Paris-Saclay), Antoine Hollebecque(Institut Gustave Roussy), Elena Fernandez-De-Sevilla(Institut Gustave Roussy), Ali Mouawia(Inserm), Ryme Bouyakoub(Institut Gustave Roussy), Anthony Tarabay(Institut Gustave Roussy), V. Boige(Institut Gustave Roussy), Karélia Lipson(Institut Gustave Roussy), Negaar Goudarzi(Inserm), David Malka(Inserm), Cristina Smolenschi(Institut Gustave Roussy), Sabrina Bedja(Inserm), Thierry de Baère(Institut Gustave Roussy)
Cited by 83
Related Papers
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k
Preoperative Radiotherapy With or Without Concurrent Fluorouracil and Leucovorin in T3-4 Rectal Cancers: Results of FFCD 9203
|Journal of Clinical Oncology|2006|1.7k
Vemurafenib in Multiple Nonmelanoma Cancers with <i>BRAF</i> V600 Mutations
|New England Journal of Medicine|2015|1.7k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k